PSORIATIC ARTHRITIS (PSA)
Clinical trials for PSORIATIC ARTHRITIS (PSA) explained in plain language.
Never miss a new study
Get alerted when new PSORIATIC ARTHRITIS (PSA) trials appear
Sign up with your email to follow new studies for PSORIATIC ARTHRITIS (PSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major drug safety check: how does this arthritis medication perform in real patients?
Disease control CompletedThis study monitored Korean patients already prescribed upadacitinib for conditions like rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Researchers tracked side effects and whether patients' symptoms improved over about 28 weeks of standa…
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Sponsor: AbbVie • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Massive study checks arthritis drug for cancer risk
Knowledge-focused CompletedThis study aimed to monitor the long-term safety of the arthritis drug abatacept after it was approved for use. It tracked over 38,000 people in Denmark with rheumatoid or psoriatic arthritis who were taking the drug. The main goal was to see how often certain cancers, especially…
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC